COMP <GO>
OPCH vs UNH // NET PROFIT MARGIN
Option Care Health Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: OPCH 8
— UNH 6
▲ NET PROFIT MARGIN LEADER: OPCH
LAST: $31.83 (-0.06%) • MKT CAP: $4.77B
net-margins
3.70%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPCH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPCH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.30% | 88.57% | -69.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 11.47% | +0.43 | OPCH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.3x | 16.4x | -1.15 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 4.55% | 6.48% | -1.93 | UNH | /fcf-yield <GO> |
| Operating Margin | 6.00% | 4.82% | +1.18 | OPCH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 3.70% | 3.14% | +0.56 | OPCH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 6.46% | +6.54 | OPCH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 3.12 | +0.69 | OPCH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.74% | +0.46 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.3 | 56.0 | +28.21 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.33 | +0.77 | OPCH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.3x | 17.1x | +2.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.77B | $364.66B | -$359.89B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPCH REV | UNH REV | OPCH GROSS % | UNH GROSS % | OPCH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.65B | $447.57B | 19.3% | 88.7% | $217.1M | $16.07B |
| FY 2024 | $5.00B | $400.28B | 20.3% | 88.3% | $287.8M | $20.70B |
| FY 2023 | $4.30B | $371.62B | 44.0% | 89.6% | $177.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPCH // BETA 1.10
UNH // BETA 0.33